Linked from

The 16 pages that link to Pulmonary function testing, each with the reason it gives.

• SpirometryNarrower topic: Spirometry is one component of this broader evaluation.

• Pulmonary hypertensionRelated: Results can reveal lung disease contributing to pulmonary hypertension.

• Pulmonary fibrosisRelated: Serial results help quantify impairment and monitor change over time.

• AsbestosisRelated: It can reveal reduced lung volumes and impaired gas transfer.

• Interstitial lung diseaseRelated: Restrictive measurements and reduced gas transfer can reveal the functional effects of ILD.

• BronchiectasisRelated: It assesses lung impairment but does not by itself establish bronchiectasis.

• Congenital myopathyRelated: Respiratory muscle weakness can require monitoring even when limb weakness is mild.

• HyperventilationRelated: Testing can help investigate respiratory disease when excessive breathing has an underlying pulmonary cause.

• MyopathyRelated: Respiratory muscle weakness in some myopathies can impair ventilation.

• SarcoidosisRelated: These tests help quantify lung impairment and track changes over time.

• PulmonologyNarrower topic: These tests provide a broader assessment than spirometry alone.

• Alpha-1 antitrypsin deficiencyRelated: These measurements track lung impairment and changes over time.

• DermatomyositisRelated: Testing helps detect and monitor lung involvement in dermatomyositis.

• LymphangioleiomyomatosisRelated: Serial tests quantify the airflow obstruction and decline that can occur in pulmonary LAM.

• Respiratory diseaseRelated: These measurements help characterize functional effects of respiratory disease.

• Pulmonary alveolar proteinosisRelated: Reduced diffusion capacity helps quantify physiological impairment.